A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

The mean monthly screening volume increased 955% in individuals aged 45 to 49 years, compared to 46% in individuals aged 50 to 75 years, study researchers reported.

Researchers suggest that tailoring interventions to symptom clusters and chemotherapy course may be best management strategy.

Researchers assessed popular social media platforms to determine the prevalence of misinformation related to prostate cancer.

No differences seen among one-, two-, and three-year interval cancer predictions, age quartiles, or breast densities.

Daneng Li, MD, of City of Hope talks about research presented at the North American Neuroendocrine Tumor Society (NANETS) 2025 meeting.

The researchers proposed adopting a standardized framework that would outline the core elements needed for informed decision-making across cancer types.

Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just days after he was placed on administrative leave while federal officials ...

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.